Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Sep-Dec;15(5-6):251-8.
doi: 10.1007/BF02590748.

Metabolic effects of glucagon in endogenous hypertriglyceridemia

R Nosadini, G Soldà, F de Biasi, A Tiengo

Metabolic effects of glucagon in endogenous hypertriglyceridemia

R Nosadini et al. Acta Diabetol Lat. 1978 Sep-Dec.

Abstract

The metabolic effects of glucagon, administered i.v. in doses of 1 microgram/kg, were evaluated in two groups of patients with endogenous hypertriglyceridemia (Types IV and V according to Fredrickson) with normal and reduced glucose tolerance and in a control group. Glucagon had a lipolytic effect, evaluated as the plasma increase of free fatty acids (FFA) during the first 20 min in normal subjects, but not in the two hyperlipemic groups. A negative correlation was observed between fasting IRI level and FFA mobilization. The ketogenic and hypotriglyceridemic effects of glucagon were demonstrated in normal and hyperlipemic groups. It would seem, therefore, that at the pharmacological doses injected, there is no resistance to the hypotriglyceridemic effect of glucagon in endogenous hypertriglyceridemia.

PubMed Disclaimer

References

    1. Lancet. 1976 Jul 3;2(7975):18-20 - PubMed
    1. Klin Wochenschr. 1966 Mar 1;44(5):262-7 - PubMed
    1. Am J Med. 1976 Jul;61(1):9-13 - PubMed
    1. J Clin Invest. 1974 Jan;53(1):190-7 - PubMed
    1. Metabolism. 1962 Dec;11:1240-9 - PubMed